Insmed (INSM) Total Liabilities (2010 - 2026)

Insmed's (INSM) quarterly Total Liabilities came in at $1.4 billion in Q1 2026, down 19.52% year-on-year from $1.7 billion in Q1 2025, and down 10.13% quarter-over-quarter from $1.5 billion in Q4 2025.

Insmed (INSM) Total Liabilities (2010 - 2026) Analysis & Trends

Insmed's Total Liabilities history runs 17 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 19.52% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 19.52% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 12.32% from the prior year.
  • Total Liabilities eased to $1.4 billion in Q1 2026 per INSM's latest filing, from $1.5 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.8 billion in Q2 2024 and bottomed at $1.0 billion in Q2 2022.
  • The 5-year median for Total Liabilities is $1.6 billion (2022), against an average of $1.5 billion.
  • Across the five-year window, Total Liabilities surged 110.58% in 2022 and tumbled 30.55% in 2025, its largest moves.
  • Year by year, Total Liabilities stood at $1.6 billion in 2022, then climbed by 5.95% to $1.7 billion in 2023, then grew by 4.7% to $1.7 billion in 2024, then slipped by 12.32% to $1.5 billion in 2025, then decreased by 10.13% to $1.4 billion in 2026.
  • Per Business Quant, the three latest INSM Total Liabilities figures stand at $1.4 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn 1.37 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.37 Bn
Dec 31, 2025 1.53 Bn
Sep 30, 2025 1.42 Bn
Jun 30, 2025 1.23 Bn
Mar 31, 2025 1.70 Bn
Dec 31, 2024 1.74 Bn
Sep 30, 2024 1.57 Bn
Jun 30, 2024 1.77 Bn
Mar 31, 2024 1.62 Bn
Dec 31, 2023 1.66 Bn
Sep 30, 2023 1.61 Bn
Jun 30, 2023 1.59 Bn
Mar 31, 2023 1.56 Bn
Dec 31, 2022 1.57 Bn
Sep 30, 2022 1.02 Bn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 1.03 Bn
Dec 31, 2021 833.04 Mn
Sep 30, 2021 806.93 Mn
Jun 30, 2021 698.73 Mn